Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Amortization of Deferred Charges (2016 - 2024)

Skinvisible's Amortization of Deferred Charges history spans 14 years, with the latest figure at $12814.0 for Q4 2024.

  • For Q4 2024, Amortization of Deferred Charges changed 0.01% year-over-year to $12814.0; the TTM value through Dec 2024 reached $50973.0, down 96.01%, while the annual FY2024 figure was $50973.0, 96.01% down from the prior year.
  • Amortization of Deferred Charges for Q4 2024 was $12814.0 at Skinvisible, roughly flat from $12813.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.2 million in Q1 2023 and bottomed at $12673.0 in Q1 2024.
  • The 5-year median for Amortization of Deferred Charges is $165067.0 (2020), against an average of $165021.0.
  • The largest annual shift saw Amortization of Deferred Charges skyrocketed 651.89% in 2023 before it tumbled 98.98% in 2024.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $168624.0 in 2020, then dropped by 10.88% to $150276.0 in 2021, then grew by 9.98% to $165276.0 in 2022, then crashed by 92.25% to $12813.0 in 2023, then rose by 0.01% to $12814.0 in 2024.
  • Per Business Quant, the three most recent readings for SKVI's Amortization of Deferred Charges are $12814.0 (Q4 2024), $12813.0 (Q3 2024), and $12673.0 (Q2 2024).